Back to Creatine

Timing & pharmacokinetics

How long does Creatine take to work?

Onset timing for Creatine varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.

Onset

Half-life

3h

Duration

Timing

anytime

Key facts

typical dose
3000–5000 mg
dose frequency
1 daily dose
timing
anytime
with food
optional
half-life
3 hours
safety score
5/5
evidence grade
A
class
amino-acid
PubMed citations
1800
legal status (US)
Over-the-counter
legal status (UK)
Over-the-counter
legal status (EU)
Over-the-counter
legal status (AU)
Over-the-counter
primary mechanism
Phosphorylated by creatine kinase to phosphocreatine, the fastest available ATP buffer in the cell (millisecond timescale).

Onset window

Creatine onset times in the published literature vary widely. Refer to the citations on the main Creatine entry for compound-specific pharmacokinetic data.

Food effect: Food has only modest effect on Creatine onset. Take with or without food depending on GI tolerance.

Half-life and dosing frequency

Short 3-hour half-life, most of the dose is cleared by mid-afternoon if taken in the morning.

Acute vs. chronic effect

Some nootropics work the first time you take them (Creatine may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges. Background on the Creatine mechanism is in the deep dive on the main entry.

If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.

Protocol note from the Creatine entry

No loading phase needed for cognitive benefit.

Mechanism, safety, and citations for Creatine are on the main reference page, see Creatine. For full dose protocol see Creatine dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.

Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.